M. Burger

发表

Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment.

T. H. van der Kwast, S. Culine, A. Broeks, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees

S. Culine, A. Horwich, J. Witjes, 2020 .